Health
Hydroxychloroquine, Mainstay Lupus Treatment, Not Associated With Serious Cardiac Complication – Newswise
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine…
Newswise — ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine, an antimalarial drug and mainstay therapy for lupus, does not appear to be associated with QTc…
Continue Reading
-
Business18 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business14 hours agoDicker Data rides the AI trend to double digit growth
-
Business22 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News22 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’